Likewise, a mutation in the SCP2 gene, encoding the SCPx enzyme, was present in a patient who exhibited progressive neurodegeneration, cardiac dysrhythmia, and metabolic abnormalities, including altered fatty acid levels and disrupted β-oxidation pathways. The gene discussed is SCP2; the disease is cardiac arrhythmia.